Company / Free Cash Flow
Alkermes plc Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$480.3M
FY2025
5-year range
-$17.2M / $480.3M
FY2021-FY2025
Trend
+18.4%
vs FY2024
Sector context
#24 of 194
Health Care
What the data says
Alkermes plc's free cash flow of $480M is higher than 88% of companies in the Health Care sector (FY2025). Free Cash Flow has increased for 3 consecutive years, from -$17M in FY2022 to $480M in FY2025.
Based on SEC 10-K filings.
$480M in FY2025 with a 5-year CAGR of +63.9%. Top quartile in the Health Care sector.
Improved from $353M to $480M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +63.9%
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 194This company $480.3M Sector average $470.6M
▼
+2.1% above sector average
Key checks
Key Insights
- Alkermes plc's free cash flow has grown for 3 consecutive years.
- 5-year CAGR of +63.9%, indicating consistent growth.
- In FY2025, free cash flow increased 18.4% year-over-year.
- Ranks #24 out of 194 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 22.3%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $480.3M | +18.4% |
| FY2024 | $405.6M | +14.8% |
| FY2023 | $353.3M | +2152.8% |
| FY2022 | -$17.2M | -123.4% |
| FY2021 | $73.7M | +81.4% |
| FY2020 | $40.6M | +315.3% |
| FY2019 | -$18.9M | -163.2% |
| FY2018 | $29.9M | +193.0% |
| FY2017 | -$32.1M | +70.1% |
| FY2016 | -$107.5M | -183.6% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026